Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05700656
Title Galunisertib Combined With Capecitabine in Advanced CRC With PM
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors The Netherlands Cancer Institute
Indications
Therapies
Age Groups: adult | senior
Covered Countries NLD

Facility Status City State Zip Country Details
Netherlands Cancer Institute RECRUITING Amsterdam 1066CX Netherlands Details
Amsterdam UMC NOT_YET_RECRUITING Amsterdam 1081 HV Netherlands Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field